Thompson Tommy G's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jun 28, 2024
- Accession no.
- 0001415889-24-018435
- Filed
- Jun 28, 2024
- Trade date
- Jun 26, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.40M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Tommy GCIK 0001324863 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | Common Stock | MOption exerciseAcquired | +7,500 | $175.43 | +$1,315,725 | 15,980 | Direct | |
| Jun 26, 2024 | Common Stock | SSaleDisposed | −5,085 | $318.81F1 | −$1,621,148.85 | 10,895 | Direct | |
| Jun 26, 2024 | Common Stock | SSaleDisposed | −1,515 | $320.21F2 | −$485,118.15 | 9,380 | Direct | |
| Jun 26, 2024 | Common Stock | SSaleDisposed | −900 | $320.84F3 | −$288,756 | 8,480 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 7,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $318.35 to $319.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $319.71 to $320.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $320.795 to $321.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.